Female Hormone Restoration

References

Acharya A, Das I, Singh S, Saha T. Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis. Recent Pat Food Nutr Agric. 2010 Jun;2(2):166-77.

Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol . 1992; 41(3–8):331–337.

Al-Akoum M, Dodin S, Akoum A. Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study. Can J Physiol Pharmacol. 2007 Nov;85(11):1153-9.

Al-Azzawi F, Bitzer J, Brandenburg U, Castelo-Branco C, Graziottin A, Kenemans P, Lachowsky M, Mimoun S, Nappi RE, Palacios S, Schwenkhagen A, Studd J, Wylie K, Zahradnik HP. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric. 2010 Apr;13(2):103-20.

Albert A, Altabre C, Baro F, et al. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine . 2002;9(2):85–92.

Ambrosone, C. B., McCann, S. E., et al. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr. 2004;134(5): 1134-1138.

Ariyo AA, Villablanca AC. Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause? Postgrad Med. 2002;111(1):23–30.

Armanini D, Fiore C, et al. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes. 2002;110(6):257-261.

Arnal, J. F., Laurell, H., et al. Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology. Climacteric. 2009;12 Suppl 1: 12-17.

Aso T. Equol improves menopausal symptoms in Japanese women. J Nutr. 2010 Jul;140(7):1386S-9S.

Atkinson C, Compston JE, Day NE, et al. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr . 2004;79(2):326–333.

Atteritano, M., Marini, H., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2007;92(8): 3068-3075.

Azoulay C. [Menopause in 2004: "hormone replacement therapy" is not what it used to be anymore]. Rev Med Interne . 2004 Nov;25(11):806–815.

Baber R. Phytoestrogens and post reproductive health. Maturitas. 2010;66(4):344-9.

Bagheri M, Joghataei MT, Mohseni S, Roghani M. Genistein ameliorates learning and memory deficits in amyloid β((1-40)) rat model of Alzheimer's disease. Neurobiol Learn Mem. 2010 Dec 7. [Epub ahead of print]

Bairey Merz CN, Johnson BD, Braunstein GD, Pepine CJ, Reis SE, Paul-Labrador M, Hale G, Sharaf BL, Bittner V, Sopko G, Kelsey SF. Phytoestrogens and lipoproteins in women. J Clin Endocrinol Metab. 2006 Jun;91(6):2209-13.

Bairey Merz CN, Johnson BD, Braunstein GD, Pepine CJ, Reis SE, Paul-Labrador M, Hale G, Sharaf BL, Bittner V, Sopko G, Kelsey SF. Phytoestrogens and lipoproteins in women. J Clin Endocrinol Metab.2006 Jun;91(6):2209-13.

Bang OY, Hong HS, Kim DH, et al. Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis . 2004;16(1):21–28.

Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer. 2004 Sep;11(3):537-51.

Barrat, J., de Lignieres, B., et al. [The in vivo effect of the local administration of progesterone on the mitotic activity of human ductal breast tissue. Results of a pilot study]. J Gynecol Obstet Biol Reprod (Paris). 1990;19(3): 269-274.

Bawa S. The significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis. J Osteoporos. 2010 Mar 8;2010:891058.

Ben-Shoshan, M., Amir, S., et al. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther. 2007;6(4): 1433-1439.

Bentrem D, Fox JE, Pearce ST, et al. Distinct molecular conformations of the estrogen receptor alpha complex exploited by environmental estrogens. Cancer Res . 2003;63(21):7490–7496.

Bernstein P, Pohost G. Progesterone, progestins, and the heart. Rev Cardiovasc Med.2010 Summer;11(3):e141-9.

Bhavnani BR. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol . 2003; 85(2–5):473–482.

Bhavnani BR. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med.1998 Jan;217(1):6-16.

Bolca, S., Urpi-Sarda, M., et al. Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr. 2010;91(4): 976-984.

Bougnoux, P., Hajjaji, N., et al. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer. 2009;101(12): 1978-1985.

Bradlow HL, Davis DL, Lin G, et al. Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ Health Perspect . 1995;103(Suppl 7):147–150.

Bradlow HL, Hershcopf R, Martucci C, et al. 16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer. Ann NY Acad Sci . 1986;464:138–151.

Bradlow HL, Telang NT , et al. 2-hydroexysterone: the good estrogen. J Endocrinol . 1996:150:259-265.

Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-hydroxyestrone: the ‘good’ estrogen. J Endocrinol. 1996 Sep;150 SupplS259-65.

Braunsberg, H. A., Coldham, N. G., et al. Hormonal therapies for breast cancer: can progestogens stimulate growth? Cancer Lett. 1986;30(2): 213-218.

Braunstein GD. Androgen insufficiency in women: summary of critical issues. Fertil Steril . 2002;77(Suppl 4):S94–S99.

Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr.2010 Jul;92(1):141-53.

Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update. 2007 Nov-Dec;13(6):559-65.

Burke BE, Olson RD , Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother . 2002;56(6):283–288.

Cameron DR , Braunstein GD. Androgen replacement therapy in women. Fertil Steri l. 2004;82(2):273-289.

Campagnoli C, Clavel-Chapelon F, et al. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol . 2005 Jul;96(2):95–108.

Campagnoli, C., Clavel-Chapelon, F., et al. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol. 2005;96(2): 95-108.

Carlson S, Peng N, Prasain JK, Wyss JM. Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females. Gend Med.2008;5 Suppl A:S76-90.

Casson PR, Faquin LC, Stentz FB, et al. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril . 1995;63(5):1027–1031.

Catherino, W. H., Jeng, M. H., et al. Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism. Br J Cancer. 1993;67(5): 945-952.

Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol. 2009 May 25;304(1-2):30-42.

Chang, K. J., Lee, T. T., et al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril. 1995;63(4): 785-791.

Chiechi LM, Putignano G, Guerra V, et al. The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial. Maturitas . 2003. 45(4):241–246.

Chlebowski RT, Anderson GL, Gass M et al. WHI Investigators. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 Oct 20;304(15):1684-92.

Cho YA, Kim J, Park KS, Lim SY, Shin A, Sung MK, Ro J. Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status. Eur J Clin Nutr.2010 Sep;64(9):924-32.

Chollet, J. A., Carter, G., et al. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause. 2009;16(5): 978-983.

Chopin LB. Vitex agnus castus essential oil and menopausal balance: a research update. Ther Nurs Midwifery . 2003;9(3):157–160.

Clair RS, Anthony M. Soy, isoflavones and atherosclerosis. Handb Exp Pharmacol. 2005;(170):301-23.

Cline, J. M., Soderqvist, G., et al. Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. Breast Cancer Res Treat. 1998;48(3): 221-229.

Colson NJ , Lea RA, et al. Investigation of hormone receptor genes in migraine. Neurogenetics . 2005 Feb;6(1):17–23. Epub 2005 Jan 15.

Cotter A, Cashman KD. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev . 2003;61(10):346–351.

Cowan LD, Gordis L, Tonascia JA, et al. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol . 1981;114(2):209–217.

Crew, K. D., Gammon, M. D., et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila). 2009;2(6): 598-604.

Crisafulli A, Marini H, Bitto A, et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause . 2004;11(4):400–404.

Cushman M. Hormone therapies and vascular outcomes: who is at risk? . J Thromb Thrombolysis . 2003;16(1–2):87–90.

Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3’-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer. 2004;50(2):161-7.

D'Anna, R., Cannata, M. L., et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. Menopause. 2009;16(2): 301-306.

Davidov, M. I., Petruniaev, A. I., et al. [Treatment of chronic cystitis in postmenopausal women]. Urologiia. 2009;(4): 14-19.

Davis SR, Moreau M, Kroll R, Bouchard C, Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008 Nov 6;359(19):2005-17.

Davison S and Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab . 2003;88(6):2470–2478.

De Kleijn MJ, van der Schouw YT, Wilson PW, et al. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr . 2002;132(2):276–282.

de Lignieres, B. Effects of progestogens on the postmenopausal breast. Climacteric. 2002;5(3): 229-235.

Dessole, S., Rubattu, G., et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause. 2004;11(1): 49-56.

Dijsselbloem N, Vanden BW, De NA., et al. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol . 2004;68(6):1171–1185.

Dimitrakakis C, Zava D, Marinopoulos S, Tsigginou A, Antsaklis A, Glaser R. Low salivary testosterone levels in patients with breast cancer. BMC Cancer. 2010 Oct 11;10:547.

Dimitrakakis C, Zhou J, Wang J, et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause . 2003;10(4):292–298.

Donnelly GF. Herbal efficacy: the case of black cohosh. Holist Nurs Pract.2007 May-Jun;21(3):103.

Donzelli, A., Braida, D., et al. Neuroprotective effects of genistein in mongolian gerbils: estrogen receptor-beta involvement. J Pharmacol Sci. 2010;114(2): 158-167.

Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem .Behav . 2003;75(3):721–729.

Dzugan SA, Arnold Smith R. Hypercholesterolemia treatment: a new hypothesis or just an accident? Med Hypotheses . 2002 Dec;59(6):751–756.

Exner M, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Held I, Gmeiner BM. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein. Free Radic Res.2001 Jan;34(1):101-12.

Exp Gerontol. 2006 Feb;41(2):117-22. Epub 2005 Dec 13.Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol.2010 Dec 21. [Epub ahead of print]

Fang ZZ, Nian Y, Li W, Wu JJ, Ge GB, Dong PP, Zhang YY, Qiu MH, Liu L, Yang L. Cycloartane triterpenoids from Cimicifuga yunnanensis induce apoptosis of breast cancer cells (MCF7) via p53-dependent mitochondrial signaling pathway. Phytother Res.2010 Jun 17. [Epub ahead of print]

Farabegoli, F., Barbi, C., et al. (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells. Cancer Detect Prev. 2007;31(6): 499-504.

Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev.1997 Feb;18(1):71-106.

Ferrari, A. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J Obstet Gynaecol Res. 2009;35(6): 1083-1090.

Fitzpatrick, L. A., Pace, C., et al. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey. J Womens Health Gend Based Med. 2000;9(4): 381-387.

Foidart, J. M., Colin, C., et al. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril. 1998;69(5): 963-969.

Fournier, A., Berrino, F., et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005;114(3): 448-454.

Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):773-9.

Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry.2006 Apr;63(4):375-82.

Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause.2007 May-Jun;14(3 Pt 2):567-71.

Gameiro C, Romao F. Changes in the immune system during menopause and aging. Front Biosci (Elite Ed). 2010 Jun 1;2:1299-303.

Gardner, C. D., Oelrich, B., et al. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate. 2009;69(7): 719-726.

Genazzani AR, Pluchino N. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence. Climacteric.2010 Aug;13(4):314-6.

Goh SY and Loh KC. Gynaecomastia and the herbal tonic "Dong Quai". Singapore Med J . 2001;42(3, pp. 115–116.

Gorodeski GI. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol.2002 Jun;16(3):329-55.

Grady D, Herrington D, Bittner V, et al: HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002 Jul 3;288(1):49-57.

Guillermo CJ, Manlove HA, Gray PB, Zava DT, Marrs CR. Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones. BMC Womens Health. 2010 May 27;10:19.

Haber D. Roads leading to breast cancer. N Engl J Med.2000 Nov 23;343(21):1566-8.

Hanna K, Wong J, Patterson C, et al. Phytoestrogen intake, excretion and markers of bone health in Australian women. Asia Pac J Clin Nutr . 2004;13(Suppl):S74.

Hardy ML. Herbs of special interest to women. J Am Pharm Assoc (Wash). 2000;40(2):234–242.

Hargrove, J. T., Maxson, W. S., et al. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone. Obstet Gynecol. 1989;73(4): 606-612.

Havlikova H, Hill M, Hampl R, et al. Sex- and age-related changes in epitestosterone in relation to pregnenolone sulfate and testosterone in normal subjects. J Clin Endocrinol Metab. 2002 May;87(5):2225-31.

Hayashi, T., Ito, I., et al. Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women. J Gerontol A Biol Sci Med Sci. 2000;55(4): B183-190; discussion B191-183.

Hayden, R. E., Pratt, G., et al. Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2. Leukemia. 2009;23(2): 292-304.

Head KA. Estriol: safety and efficacy. Altern Med Rev. 1998;3(2):101–113.

Helguero LA, Faulds MH, Gustafsson JA, Haldosén LA. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene.2005 Oct 6;24(44):6605-16.

Henderson VW. Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol.2008 Sep;51(3):618-26.

Hillard T. The postmenopausal bladder. Menopause Int.2010 Jun;16(2):74-80.

Hilton, H. N., Kalyuga, M., et al. The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5. Mol Endocrinol. 2010;24(7): 1380-1392.

Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril . 1997;68(6):981–986.

Hissom, J. R. and Moore, M. R. Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications. Biochem Biophys Res Commun. 1987;145(2): 706-711.

Ho SC, Wu S, Chan SG, Sham A. Menopausal transition and changes of body composition: a prospective study in Chinese perimenopausal women. Int J Obes (Lond).2010 Aug;34(8):1265-74.

Hofseth, L. J., Raafat, A. M., et al. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab. 1999;84(12): 4559-4565.

Holtorf, K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad Med. 2009;121(1): 73-85.

Holzer, G., Esterbauer, H., et al. The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC. Thromb Res. 2007;120(1): 71-79.

Hostanska K, Nisslein T, Freudenstein J, et al. Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol Pharm Bull . 2004;27(12):1970–1975.

Hsuuw, Y. D. and Chan, W. H. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann N Y Acad Sci. 2007;1095: 428-440.

Hu C, Liu H, Du J, Mo B, Qi H, Wang X, Ye S, Li Z. Estrogenic activities of extracts of Chinese licorice (Glycyrrhiza uralensis) root in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):209-16.

Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA . 2002;288(1):58–66.

Ignatov A, Ignatov T, Roessner A, Costa SD, Kalinski T. Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res Treat. 2010 Aug;123(1):87-96.

Inoh, A., Kamiya, K., et al. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats. Jpn J Cancer Res. 1985;76(8): 699-704.

Isaksson E, Wang H, Sahlin L, von Schoultz B, Masironi B, von Schoultz E, Cline JM. Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast.2002 Aug;11(4):295-300.

Ishiko, O., Hirai, K., et al. Hormone replacement therapy plus pelvic floor muscle exercise for postmenopausal stress incontinence. A randomized, controlled trial. J Reprod Med. 2001;46(3): 213-220.

Itoi, H., Minakami, H., et al. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen on serum lipid profile in early menopausal women. Maturitas. 2000;36(3): 217-222.

Jamshidi, F., Zhang, J., et al. Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling. Cell Cycle. 2008;7(7): 917-924.

Jeng, M. H., Parker, C. J., et al. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res. 1992;52(23): 6539-6546.

Jensen, J., Riis, B. J., et al. Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol. 1987;156(1): 66-71.

Jia TL, Wang HZ, Xie LP, et al. Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol . 2003;65(5):709–715.

Josephs RA, Guinn JS, Harper ML, Askari F. Liquorice consumption and salivary testosterone concentrations. Lancet.2001 Nov 10;358(9293):1613-4.

Kalkhoven, E., Kwakkenbos-Isbrucker, L., et al. Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol. 1994;102(1-2): 45-52.

Kall MA, Vang O, Clausen J. Effects of dietary broccoli on human drug metabolising activity. Cancer Lett. 1997 Mar 19;114(1-2):169-70.

Kanno S, Hirano S, Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology . 2004;196(1-2):137–145.

Kano, H., Hayashi, T., et al. Estriol retards and stabilizes atherosclerosis through an NO-mediated system. Life Sci. 2002;71(1): 31-42.

Kansal, S., Negi, A. K., et al. Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(alpha)anthracene-induced mammary carcinogenesis. Tumour Biol. 2010.

Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res.2000;55:163-93; discussion 194-5.

Kenny AM, Boxer RS, et al: Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc.2010 Sep;58(9):1707-14.

Kgomotso T, Chiu F, Ng K. Genistein- and daidzein 7-O-beta-D-glucuronic acid retain the ability to inhibit copper-mediated lipid oxidation of low density lipoprotein. Mol Nutr Food Res. 2008 Dec;52(12):1457-66.

Ko, K. P., Park, S. K., et al. Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(5): 1292-1300.

Kobata, S. A., Girao, M. J., et al. Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis. Maturitas. 2008;61(3): 243-247.

Koloszar, S. and Kovacs, L. Treatment of climacteric urogenital disorders with an estriol-containing ointment. Orv Hetil. 1995;136(7): 343-345.

Kolovou GD, Bilianou HG. Influence of aging and menopause on lipids and lipoproteins in women. Angiology. 2008 Apr-May;59(2 Suppl):54S-7S.

Komesaroff PA, Black CV, Cable V, et al. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric . 2001;4(2):144–150.

Kubista E. Diagnosis and therapy of fibrocystic breast disease. Zentralbl Gynakol . 1990;112(17):1091–1096.

Kuipe GG, Shughrue PJ, Merchenthaler I, et al. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol . 1998;19(4):253–286.

Kuo, BT., Choubey, R., et al. Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy. Gend Med. 2010;7(1): 71-77.

Labrie F. DHEA, important source of sex steroids in men and even more in women. Prog Brain Res.2010;182:97-148.

Laidlaw M, Cockerline CA, Sepkovic DW. Effects of A Breast-Health Herbal Formula Supplement on Estrogen Metabolism in Pre- and Post-Menopausal Women not Taking Hormonal Contraceptives or Supplements: A Randomized Controlled Trial. Breast Cancer (Auckl).2010 Dec 16;4:85-95.

Lampe JW. Interindividual differences in response to plant-based diets: implications for cancer risk. Am J Clin Nutr.2009 May;89(5):1553S-1557S. Epub 2009 Mar 18.

Lappano R, Rosano C, De Marco P, Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol.2010 May 14;320(1-2):162-70.

Lappe, J. M., Travers-Gustafson, D., et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6): 1586-1591.

Lauritzen, C. Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints. Horm Metab Res. 1987;19(11): 579-584.

Lee J.R. and Hopkins V. What Your Doctor May Not Tell You About Menopause: The Breakthrough Book on Natural Progesterone. New York: Warner Books, 1996.

Lee SC, Kaunitz AM, Sanchez-Ramos L, Rhatigan RM. The oncogenic potential of endometrial polyps: a systematic review and meta-analysis. Obstet Gynecol.2010 Nov;116(5):1197-205.

Lee, HJ., Ji, Y., et al. Activation of bone morphogenetic protein signaling by a Gemini vitamin D3 analogue is mediated by Ras/protein kinase C alpha. Cancer Res. 2007;67(24): 11840-11847.

Lenfant F, Trémollières F, Gourdy P, Arnal JF. Timing of the vascular actions of estrogens in experimental and human studies: Why protective early, and not when delayed? Maturitas.2010 Dec 15. [Epub ahead of print]

Leong, H., Mathur, P. S., et al. Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea. Breast Cancer Res Treat. 2008;107(3): 359-369.

Lian Z, Niwa K, Tagami K, et al. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn J Cancer Res . 2001;92(7):726–734.

Liang, K., Yang, L., et al. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J Biol Chem. 2010;285(2): 935-942.

Lindenfeld, E. A. and Langer, R. D. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial. Obstet Gynecol. 2002;100(5 Pt 1): 853-863.

Linford NJ, Dorsa DM, et al. 17beta-estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium ATPase inhibitor thapsigargin. Steroids. 2002;67(13-14):1029-1040.

Ling S, Komesaroff PA, Sudhir K. Cardiovascular physiology of androgens and androgen testosterone therapy in postmenopausal women. Endocr Metab Immune Disord Drug Targets. 2009 Mar;9(1):29-37.

Lose, G. and Englev, E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG. 2000;107(8): 1029-1034.

Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women. J Clin Endocrinol Metab. 2001 Jul;86(7):3045-52.

Lu LJ, Cree M, Josyula S, et al. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res . 2000;60(5):1299–1305.

Ma DF, Qin LQ, Wang PY, Katoh R. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr.2008 Feb;27(1):57-64. Epub 2007 Dec 11.

Ma, Y., Sullivan, J. C., et al. Dietary genistein and equol (4', 7 isoflavandiol) reduce oxidative stress and protect rats against focal cerebral ischemia. Am J Physiol Regul Integr Comp Physiol. 2010;299(3): R871-877.

Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010 Jan;85(1):87-94.

Maia H Jr, Casoy J, Valente J. Testosterone replacement therapy in the climacteric: benefits beyond sexuality. Gynecol Endocrinol.2009 Jan;25(1):12-20.

Malet, C., Spritzer, P., et al. Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture. J Steroid Biochem Mol Biol. 2000;73(3-4): 171-181.

Mandal CC, Ghosh-Choudhury T, Yoneda T, Choudhury GG, Ghosh-Choudhury N. Fish oil prevents breast cancer cell metastasis to bone. Biochem Biophys Res Commun. 2010 Nov 26;402(4):602-7.

Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2009 Jan;30(1):65-91.

Marini, H., Bitto, A., et al. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. Nutr Metab Cardiovasc Dis. 2010;20(5): 332-340.

Martin-Du Pan R. [Androgen deficiency in women: indication and risks of testosterone or DHEA treatment]. Rev Med Suisse. 2007 Mar 28;3(104):792-6.

Masuda, M., Suzui, M., et al. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol. 2002;2(6): 350-359.

Mauvais-Jarvis, P., Kuttenn, F., et al. Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat. 1986;8(3): 179-188.

Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev . 2004 Nov;5(4):197–216.

Melamen M, Castano E, Notides AC et al. Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol. Mol Endocrinol.1997 Nov;11(12):1868-78.

Mellon SH. Neurosteroid regulation of central nervous system development. Pharmacol Ther.2007 Oct;116(1):107-24.

Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J. 2008 Jun 3;7:17.

Michnovicz JJ, Adlercreutz H, Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst. 1997 May 21;89(10):718-23.

Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer. 1991;16(1):59-66.

Michnovicz JJ. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol. Int J Obes Relat Metab Disord. 1998 Mar;22(3):227-9.

Minaguchi, H., Uemura, T., et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study. J Obstet Gynaecol Res. 1996;22(3): 259-265.

Miyake A, Takeda T, Isobe A, et al: Repressive effect of the phytoestrogen genistein on estradiol-induced uterine leiomyoma cell proliferation. Gynecol Endocrinol.2009 Jun;25(6):403-9.

Montenegro MF, Pessa LR, Tanus-Santos JE. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. Eur J Pharmacol.2009 Apr 1;607(1-3):173-7.

Montplaisir, J., Lorrain, J., et al. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause. 2001;8(1): 10-16.

Morrison MF, Redei E, TenHave T, et al: Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population. Biol Psychiatry.2000 Jan 15;47(2):144-50.

Moskowitz D. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Altern Med Rev. 2006 Sep;11(3):208-23.

Mueck, A. O., Seeger, H., et al. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition. Climacteric. 2003;6(3): 221-227.

Muti P, Bradlow HL, Micheli A, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology . 2000;11(6):635–640.

Muti P, Westerlind K, Wu T, et al. Urinary estrogen metabolites and prostate cancer: a case-control study in the United States. Cancer Causes Control. 2002 Dec;13(10):947-55.

Muti, P., Bradlow, H. L., et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology. 2000;11(6): 635-640.

Nilsson S, Mäkelä S, Treuter E, Tujague M, Mechanisms of estrogen action. Physiol Rev.2001 Oct;81(4):1535-65.

Nishibe, A., Morimoto, S., et al. Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women. Nippon Ronen Igakkai Zasshi. 1996;33(5): 353-359.

Nisslein T and Freudenstein J. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner Metab . 2003;21(6):370–376.

Notelovitz M. Androgen effects on bone and muscle. Fertil Steril . 2002;77(Suppl 4):S34–S41.

Nozaki, M., Hashimoto, K., et al. Usefulness of estriol for the treatment of bone loss in postmenopausal women. Nippon Sanka Fujinka Gakkai Zasshi. 1996;48(2): 83-88.

Ofir R, Tamir S, et al. Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci . 2003;20(2):135-140.

Okamura, S., Sawada, Y., et al. Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes. Tohoku J Exp Med. 2008;216(4): 341-351.

Oktem M, Eroglu D, Karahan HB, et al: Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther.2007 Mar-Apr;24(2):448-61.

Ory, K., Lebeau, J., et al. Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines. Breast Cancer Res Treat. 2001;68(3): 187-198.

Ottosson, U. B., Johansson, B. G., et al. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone. Am J Obstet Gynecol. 1985;151(6): 746-750.

Ozyazgan, I., Liman, N., et al. The effects of topical estriol and vehicle cream on the mechanical and histological properties of normal rat skin. Med Sci Monit. 2005;11(11): BR405-411.

Paech K, Webb P, Kuiper GG et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science.1997 Sep 5;277(5331):1508-10.

Papa, V., Reese, C. C., et al. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res. 1990;50(24): 7858-7862.

Papaconstantinou AD, Umbreit TH, Fisher BR, et al. Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor. Toxicol Sci . 2000;56(2):332–339.

Park D, Huang T, Frishman WH. Phytoestrogens as cardioprotective agents. Cardiol Rev . 2005;13(1):13–17.

Park, M. K., Kwon, H. Y., et al. Estrogen activities and the cellular effects of natural progesterone from wild yam extract in mcf-7 human breast cancer cells. Am J Chin Med. 2009;37(1): 159-167.

Paruthiyil S, Parmar H, Kerekatte V, et al. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 2004 Jan 1;64(1):423-8.

Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab.2009 Dec;94(12):4776-84.

Ragaz Joseph et al. Hormone replacement therapy utilizing estrogen alone provides a protective effect in reducing breast cancer risk. 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 8-12, 2010.

Rassi CM, Lieberherr M, Chaumaz G, et al. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J Bone Miner Res . 2002;17(4):630–638.

Raz, R. and Stamm, W. E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11): 753-756.

Rich RL, Hoth LR, Geoghegan KF, Brown TA, LeMotte PK, Simons SP, Hensley P, Myszka DG. Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci U S A.2002 Jun 25;99(13):8562-7.

Ritsner MS, Gibel A, Shleifer T, et al: Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry.2010 Oct;71(10):1351-62.

Rocca WA, Bower JH, Maraganore DM, et al: Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology. 2008 Jan 15;70(3):200-9.

Rosano, G. M., Webb, C. M., et al. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J Am Coll Cardiol. 2000;36(7): 2154-2159.

Rossouw JE, Anderson GL, Prentice RL, et al: Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-33.

Rossouw JE, Prentice RL, Manson JE, et al: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007 Apr 4;297(13):1465-77.

Roumie CL, Grogan EL, Falbe W, et al: A three-part intervention to change the use of hormone replacement therapy in response to new evidence. Ann Intern Med. 2004 Jul 20;141(2):118-25.

Ryan, N. and Rosner, A. Quality of life and costs associated with micronized progesterone and medroxyprogesterone acetate in hormone replacement therapy for nonhysterectomized, postmenopausal women. Clin Ther. 2001;23(7): 1099-1115.

Samsioe G. The menopause revisited. Int J Gynaecol Obstet . 1995;51(1):1–13.

Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest . 2003;21(5):744–757.

Sarotra P, Sharma G, Kansal S,. Chemopreventive effect of different ratios of fish oil and corn oil in experimental colon carcinogenesis. Lipids.2010 Sep;45(9):785-98.

Sarotra, P., Sharma, G., et al. Chemopreventive effect of different ratios of fish oil and corn oil in experimental colon carcinogenesis. Lipids. 2010;45(9): 785-798.

Sassarini J, Lumsden MA. Hot flushes: are there effective alternatives to estrogen? Menopause Int.2010 Jun;16(2):81-8.

Schmidt, J. B., Binder, M., et al. Treatment of skin aging with topical estrogens. Int J Dermatol. 1996;35(9): 669-674.

Schneider HP. Androgens and antiandrogens. Ann NY Acad Sci . 2003;997:292-306.

Schonberg, M. A., Davis, R. B., et al. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Womens Health Issues. 2005;15(4): 187-195.

Schreihofer, D. A. and Redmond, L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience. 2009;158(2): 602-609.

Shams T, Setia MS, Hemmings R, et al: Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis. Altern Ther Health Med. 2010 Jan-Feb;16(1):36-44.

Sharma S. Hormone Replacement Therapy in menopause: current concerns and considerations. Kathmandu Univ Med J (KUMJ). 2003 Oct-Dec;1(4):288-93.

Simon JA. Safety of estrogen/androgen regimens. J Reprod Med. 2001 Mar;46(3 Suppl):281-90.

Simone CB. Cancer and Nutrition. Lawrenceville, NJ: Princeton Institute; 2005.

Sirtori CR. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf.2001;24(9):665-82.

Sitruk-Ware, R. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation. Climacteric. 2007;10(5): 358-370.

Soares CN, Poitras JR, and Prouty J. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging . 2003;20(2):85–100.

Somjen D. Knoll E, Vaya J, et al. Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo. J Steroid Biochem Mol Biol . 2004;91(3):147–155.

Stein DG. The case for progesterone. Ann NY Acad Sci . 2005 Jun;1053;152–169.

Stuckey BG. Female sexual function and dysfunction in the reproductive years: the influence of endogenous and exogenous sex hormones. J Sex Med. 2008 Oct;5(10):2282-90.

Sturgeon SR, Ronnenberg AG. Pomegranate and breast cancer: possible mechanisms of prevention. Nutr Rev.2010 Feb;68(2):122-8.

Swami, S., Krishnan, A. V., et al. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. Int J Cancer. 2009;124(9): 2050-2059.

Taioli E, Im A, Xu X, et al. Comparison of estrogens and estrogen metabolites in human breast tissue and urine. Reprod Biol Endocrinol.2010 Aug 2;8:93.

Takahashi, K., Okada, M., et al. Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause. Hum Reprod. 2000;15(5): 1028-1036.

Taku K, Melby MK, Kurzer MS, et al: Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials. Bone.2010 Aug;47(2):413-23.

Tapiero H, Ba GN et al. Estrogens and environmental estrogens. Biomed Pharmacother . 2002 Feb;56(1):36–44.

Taylor CK, Levy RM, Elliott JC, Burnett BP. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev.2009 Jul;67(7):398-415.

Taylor M. Unconventional estrogens: estriol, biest, and triest. Clin Obstet Gynecol . 2001;44(4):864–879.

Teede HJ, Dalais FS, Kotsopoulos D, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab . 2001 Jul;86(7):3053-60.

Thangapazham, R. L., Passi, N., et al. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther. 2007;6(12): 1938-1943.

Thangapazham, R. L., Singh, A. K., et al. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007;245(1-2): 232-241.

Thompson, L. U., Chen, J. M., et al. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005;11(10): 3828-3835.

Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis.2003;6(2):121-8.

Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev.2006 Oct;27(6):575-605.

Tzingounis, V. A., Aksu, M. F., et al. Estriol in the management of the menopause. JAMA. 1978;239(16): 1638-1641.

Vallée M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12.

van der Schouw YT, Pijpe A, Lebrun CE, Bots ML, Peeters PH, van Staveren WA, Lamberts SW, Grobbee DE. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1316-22.

Vij U, Kumar A. Phyto-oestrogens and prostatic growth. Natl Med J India . 2004;17(1):22–26.

Vincent A, Fitzpatrick LA. Soy isoflavones: are they useful in menopause? Mayo Clin Proc . 2000;75(11):1174–1184.

Walsh B and Schiff I. Menopause. In Principles and Practice of Endocrinology and Metabolism . New York : Lippincott, Williams and Williams; 2001.

Wang D, Hu L, Zhang G, Zhang L, Chen C. G protein-coupled receptor 30 in tumor development. Endocrine.2010 Aug;38(1):29-37.

Watt PJ, Hughes RB, et al. A holistic programmatic approach to natural hormone replacement. Fam Community Health . 2003;25(1):53-63.

Weatherman RV, Clegg NJ, Scanlan TS. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites. Chem Biol.2001 May;8(5):427-36.

Weiss EP, Shah K, Fontana L, et al: Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. 2009 May;89(5):1459-67.

Weiss EP, Shah K, Fontana L, Lambert CP, Holloszy JO, Villareal DT. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr.2009 May;89(5):1459-67.

Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006 May;116(5):1186-94.

Weng JR, Tsai CH, Kulp SK, Chen CS. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett.2008 Apr 18;262(2):153-63.

Wong GY, Bradlow L, Sepkovic D, et al. Dose-ranging study of indole-3-carbinol for breast cancer prevention. J Cell Biochem Suppl. 1997;28-29:111-6.

Wood, C. E., Register, T. C., et al. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res Treat. 2007;101(2): 125-134.

Wren BG. The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women. Med J Aust. 2009 Mar 16;190(6):321-5.

Wright J. Stay Young and Sexy with Bio-Identical Hormone Replacement: The Science Explained. Published Dec. 16th 2009.

Wright JV, Schliesman B, Robinson L. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Altern Med Rev. 1999 Aug;4(4):266-70.

Xu, L., Ding, Y., et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst. 2009;101(16): 1141-1155.

Yamaguchi M, Sugimoto E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase. Mol Cell Biochem . 2000;214(1–2):97–102.

Yamanaka, Y., Matsuo, H., et al. Effects of combined estriol/pravastatin therapy on intima-media thickness of common carotid artery in hyperlipidemic postmenopausal women. Gynecol Obstet Invest. 2005;59(2): 67-69.

Yang, S., Zhou, Q., et al. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta. 2007;1773(6): 903-911.

Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci . 1995;774):128–142.

Yu, H. L., Li, L., et al. Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by beta-amyloid 31-35. Br J Nutr. 2009;102(5): 655-662.

Zhang Y, Jin H, Xu Z, et al. Effects of genistein on bone mineral density and biomechanical properties and morphometric parameters in ovariectomized rats. Wei Sheng Yan Jiu . 2004;33(4):464–466.

Zhou J, Ng S, et al: Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J . 2000;14(12):1725–1730.

Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. Endocrinology.2006 Sep;147(9):4132-50.